| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.641 | 8.820 | 9.463 | 8.260 | 18.371 | 14.685 | 14.828 | 13.152 | 14.970 | 19.237 |
| Total Income - EUR | 8.641 | 8.820 | 9.463 | 8.260 | 18.371 | 14.685 | 14.828 | 13.152 | 14.970 | 19.237 |
| Total Expenses - EUR | 6.626 | 6.347 | 7.251 | 9.537 | 14.922 | 12.611 | 12.134 | 12.106 | 14.129 | 15.028 |
| Gross Profit/Loss - EUR | 2.015 | 2.473 | 2.212 | -1.277 | 3.449 | 2.074 | 2.694 | 1.047 | 841 | 4.208 |
| Net Profit/Loss - EUR | 1.755 | 2.209 | 1.928 | -1.519 | 3.265 | 1.932 | 2.546 | 915 | 691 | 3.643 |
| Employees | 1 | 1 | 1 | 1 | 2 | 2 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Alergo-Med Isoc Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 581 | 356 | 139 | 0 | 0 | 0 |
| Current Assets | 1.683 | 2.096 | 2.174 | 627 | 2.159 | 2.567 | 3.365 | 1.881 | 1.831 | 4.919 |
| Inventories | 195 | 25 | 451 | 583 | 71 | 93 | 107 | 125 | 54 | 612 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 1.488 | 2.071 | 1.723 | 45 | 2.088 | 2.474 | 3.258 | 1.756 | 1.777 | 4.307 |
| Shareholders Funds | 1.503 | 1.930 | 1.981 | -1.467 | 1.827 | 1.982 | 2.594 | 964 | 740 | 3.691 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 180 | 166 | 194 | 2.095 | 913 | 941 | 910 | 917 | 1.091 | 1.229 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alergo-Med Isoc Srl